Vaccine developer Novavax Inc. said on Sept. 8 the company initiated an early-stage study to test a combination of the flu shot NanoFlu and the Covid-19 vaccine NVX-CoV2373.
Genetic testing specialist Qiagen received emergency use authorization for a new coronavirus test from the U.S. drugs regulator.
Thermo Fisher Scientific is acquiring Mesa Biotech for about $450 million in cash, and will pay an additional $100 million in cash after certain milestones are hit.
According to the Pharmaceutical Research and Manufacturers of America (PhRMA), there are 264 vaccines in development to prevent and treat diseases.
The U.S. Food and Drug Administration approved Sanofi’s new pediatric vaccine immunizing children against six diseases.